Author

A. S. Thickens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

R. Hernandez· 2 shared A. Carston· 1 shared A. Pinchuk· 1 shared B. Bednarz· 1 shared C. Choi· 1 shared C. de Aguiar Ferreira· 1 shared C. Massey· 1 shared D. G. McNeel· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

R. Hernandez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Investigating the in vivo biodistribution of extracellular vesicles isolated from various human cell sources using positron emission tomography

Z. T. Rosenkrans, A. S. Thickens, J. A. Kink, E. Aluicio-Sarduy, J. W. Engle, P. Hematti, R. Hernandez

This study uses PET imaging to track the in vivo biodistribution of extracellular vesicles from different human cell sources, revealing tissue-specific uptake patterns and highlighting the importance of cell source selection for therapeutic applications.

Molecular Pharmaceutics · Aug 21, 2024Peer-reviewedBioengineering

Profound immunomodulatory effects of 225Ac-NM600 drive enhanced anti-tumor responsein prostate cancer

C. de Aguiar Ferreira, H. K. Potluri, C. Massey, J. J. Grudzinski, A. Carston, N. Clemons, A. S. Thickens, Z. Rosenkrans, C. Choi, A. Pinchuk, O. Kwon, J. J. Jeffery, B. Bednarz, Z. Morris, J. Weichert, , R. Hernandez

This study shows that 225Ac-NM600, an alpha-emitting radiopharmaceutical, enhances anti-tumor responses in prostate cancer by modulating the immune microenvironment.

bioRxiv · Sep 26, 2022 · PreprintImmunology